Impact of private equity on hospice care quality and costs
Do Acquisitions of Hospice Agencies by Private Equity Firms and Publicly Traded Corporations Impact End-of-Life Quality and Cost of Care?
This study looks at how when private companies buy hospice agencies, it impacts the quality and cost of care for patients at the end of their lives, especially for older adults, and aims to find ways to make that care better.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11018587 on NIH RePORTER |
What this research studies
This research investigates how the acquisition of hospice agencies by private equity firms and publicly traded corporations affects the quality and cost of end-of-life care for patients. The project aims to assess various policy interventions and delivery models of hospice care, focusing on improving care for the elderly. Through qualitative studies and collaboration with experienced mentors, the research will analyze the implications of corporate ownership on patient satisfaction and care delivery.
Who could benefit from this research
Good fit: Ideal candidates for this research are elderly patients receiving hospice care or their families who are interested in understanding the impact of corporate ownership on their care.
Not a fit: Patients who are not currently receiving hospice care or those who are not elderly may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved end-of-life care practices and policies that enhance the quality of life for hospice patients.
How similar studies have performed: While the impact of corporate ownership on healthcare delivery is a growing area of interest, this specific focus on hospice care is relatively novel and has not been extensively studied.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Braun, Robert Tyler — Weill Medical Coll of Cornell Univ
- Study coordinator: Braun, Robert Tyler
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.